BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ideon - ECPv6.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ideon
X-ORIGINAL-URL:https://ideon.se
X-WR-CALDESC:Events for ideon
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20250925T083000
DTEND;TZID=Europe/Stockholm:20250925T150000
DTSTAMP:20260629T163955
CREATED:20250917T120312Z
LAST-MODIFIED:20250917T122433Z
UID:385418-1758789000-1758812400@ideon.se
SUMMARY:From Discovery to Breakthrough: Driving Innovation in Biotherapeutics Development
DESCRIPTION:Supporting Growth in Emerging Biotech\nBiotechnology startups face challenges in advancing therapeutic programs\, from outsourcing key processes to scaling in-house operations. Moving from discovery to large-scale production is complex and resource-intensive. \nThis Academy is tailored for emerging biotech companies seeking practical solutions. Through integrated strategies\, case studies\, and innovative technologies\, it will highlight ways to streamline research and manufacturing. \nCollaboration and innovation are central to accelerating the path from discovery to breakthrough. Thermo Fisher Scientific is committed to enabling customers to make the world healthier\, cleaner\, and safer. \nKey Take Aways \n\nComprehensive Support for Biotech Development throughout the entire development pipeline\, from initial research to clinical applications\, ensuring a seamless transition through each stage.\nInnovative Strategies in Process Development and Scale-Up biotherapeutic production while maintaining quality and consistency.\nCase studies and hands-on experience of the innovative 5L DynaDrive benchtop bioreactor\, showcasing its capabilities and benefits in optimizing biotherapeutic development processes.\n\nProgramme \n08:30-09:00 | Registration & coffee with croissant\n09:00-09:10 | Welcome & introductions\n09:10-09:35 | Supporting biotech from research to clinic\n09:35-10:35 | Session 1: Discovery & early development – Key Insights and Best Practices\nFocus: Increasing yield\, ensuring quality\, and accelerating early-stage development.\nTopics:\nBest practices for handling and expanding sensitive cell types\nStrategies to improve cell culture performance with tailored Fetal Bovine Serum Solutions\n10:35-10:50 | Networking & coffee break\n10:50-12:00 | Session 2: Process development & scale up – Streamlining Upstream and Downstream Operations\nFocus: Efficiency\, scalability\, and maintaining quality as you scale from benchtop to commercialization.\nTopics: \n\nEnhancing upstream process with cell culture and services solutions: from benchtop to large scale manufacture\nDownstream purification strategies and vest practices for maintaining product yield and quality\nStart small to move fast: How to scale up from benchtop to large production with single-use bioreactors\nProduction of chemicals & services: Ensuring consistent quality and regulatory compliance at scale\nCase studies with the newest technology – 5L DynaDrive Single-Use Bioreactor\n\n12:00-12:50 | 5L DynaDrive benchtop bioreactor demo in groups (please register your interest at the registration form) & lunch break\n12:50-13:00 | Closing remarks\n13:00 | Networking over coffee \nMeet the Experts \n\nNatraj Ram – VP of Innovation\, Bioproduction\nSofia Holback – Sr. Product Specialist\, Neuro & Stem Cells\, Cell therapy\nCatarina Antropow – Product Specialist\, GIBCO Serum\nAlexandre Callot – Sr. Product Specialist\, Production Chemicals & Services\nLorena Marin – Sr. Product Specialist\, Cell Culture & Cell Therapy\nJesper Larsen – FAS\, Single-use Technologies\nGirish Kumar Maurya – Biotech Account Manager\nGert Von Kiaer – Sr. Product Specialist\, Single-Use Technologies\nMaria Bartel – Sr. Product Specialist\, Purification\nTom Drake – Product Specialist\nJonathan Nugent – Sr. Product Specialist\, Production Chemicals & Services\n\nAbout Thermo Fisher Scientific\nThermo Fisher Scientific Inc. is a global company in serving science\, with annual revenue over $40 billion. Their mission is to enable customers to make the world healthier\, cleaner and safer. Whether their customers are accelerating life sciences research\, solving complex analytical challenges\, increasing productivity in their laboratories\, improving patient health through diagnostics or the development and manufacture of life-changing therapies\, Thermo Fisher Scientific is ready to provide support. \n  \nSign Up!
URL:https://ideon.se/event/from-discovery-to-breakthrough-driving-innovation-in-biotherapeutics-development/
LOCATION:Medicon Village (The Spark\, lokal Shariance)\, Scheeletorget 1\, Lund\, 223 63\, United States
CATEGORIES:Seminar
ATTACH;FMTTYPE=image/jpeg:https://ideon.se/wp-content/uploads/2025/09/Academy-ThermoFischer-1920x1080-1.jpg
ORGANIZER;CN="Medicon Village in collaboration with Thermo Fisher Scientific":MAILTO:dimitra.manou@mediconvillage.se
END:VEVENT
END:VCALENDAR